Similarly, OTUD6B-AS1 played a tumor-suppressive role in thyroid carcinoma (Wang Z. et al., 2020), bladder carcinoma (Wang Y. et al., 2020), and CRC (Cai et al., 2021; Wang et al., 2021). Here, OTUD6B is linked to urinary bladder carcinoma.